atomoxetine hydrochloride has been researched along with Adverse Drug Event in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 7 (31.82) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dubrall, D; Leitzen, S; Neubert, A; Sachs, B; Schmid, M; Schulz, M; Stingl, J; Toni, I | 1 |
| Banaschewski, T; Bölte, S; Buitelaar, JK; Coghill, D; Cortese, S; Häge, A; Hohmann, S; Jonsson, U; Nobel Norrman, H; Pan, PY; Şahpazoğlu Çakmak, SS | 1 |
| Bachmann, C; Biscaldi-Schäfer, M; Clement, HW; Fleischhaker, C; Geffert, C; Haberhausen, M; Ruppert, K; Schulz, E | 1 |
| Cortese, S; Groom, MJ | 1 |
| Gün, E; Kocabay, K | 1 |
| Campbell, TJ; McGrane, IR | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Antoniazzi, S; Carnovale, C; Clementi, E; Gentili, M; Nobile, M; Peeters, GGAM; Pozzi, M; Radice, S | 1 |
| Coskun, M; Gülle, ZN; Karayagmurlu, A | 1 |
| Allen, AJ; Greenhill, LL; Newcorn, JH; Ruff, DD; Wietecha, LA | 1 |
| Allen, AJ; Escobar, R; Kryzhanovskaya, LA; Lane, JR; Lipsius, S; Tanaka, Y; Trzepacz, PT; Upadhyaya, H | 1 |
| Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y | 1 |
| Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R | 1 |
| Hilt, R; Kwan, AC; Lee, T; McClellan, J; Thompson, JN; Trupin, E; Varley, CK | 1 |
| Ball, SG; Bangs, M; Donnelly, C; Jin, L; Spencer, TJ; Trzepacz, P; Witte, MM; Zhang, S | 1 |
| Bateman, N; Bond, C; Helms, PJ; Lee, AJ; McCaig, D; McLay, J; Stewart, D; Tobaiqy, M | 1 |
| Niederhofer, H | 1 |
| Chung, K; Duong, S; Wigal, SB | 1 |
| Livio, F | 1 |
| Bilker, WB; Cziraky, MJ; Daniel, GW; Guevara, JP; Hennessy, S; Kimmel, SE; Newcomb, C; Schelleman, H; Strom, BL | 1 |
| Garcia-Bournissen, F; Humphreys, C; Ito, S; Koren, G | 1 |
9 review(s) available for atomoxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Headache; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2022 |
Current Pharmacological Treatments for ADHD.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Methylphenidate; Quality of Life | 2022 |
Probable Genitourinary Adverse Events Associated With Atomoxetine in an Adult Male: A Case Report.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Propylamines; Treatment Outcome | 2021 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis.
Topics: Affect; Affective Symptoms; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Mood Disorders; Personality Disorders | 2018 |
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome | 2017 |
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Comorbidity; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Humans; Methylphenidate; Propylamines | 2012 |
[Pharmacovigilance update].
Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Amides; Antihypertensive Agents; Atomoxetine Hydrochloride; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Fibrinolytic Agents; Fumarates; Hemorrhage; Humans; Pharmacovigilance; Propylamines | 2013 |
Exposure to attention deficit hyperactivity disorder medications during pregnancy.
Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Congenital Abnormalities; Decision Making; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Methylphenidate; Pregnancy; Pregnancy Complications; Propylamines; Risk Assessment | 2007 |
3 trial(s) available for atomoxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Outcome Assessment, Health Care; Propylamines; Time Factors | 2013 |
Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Female; Heart Rate; Humans; Male; Time Factors; Treatment Outcome; Withholding Treatment | 2015 |
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Hostility; Humans; Male; Propylamines; Psychiatric Status Rating Scales; Treatment Outcome; Vital Signs | 2009 |
10 other study(ies) available for atomoxetine hydrochloride and Adverse Drug Event
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.
Topics: Adolescent; Atomoxetine Hydrochloride; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etanercept; Female; Germany; Humans; Ibuprofen; Infant; Infant, Newborn; Male; Methylphenidate; Off-Label Use; Palivizumab; Pharmacovigilance | 2021 |
Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Child; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Propylamines; Retrospective Studies; Treatment Outcome | 2022 |
Use of Intravenous Lipid Emulsion Therapy in a Case of Atomoxetine (Strattera®) Toxicity.
Topics: Adolescent; Atomoxetine Hydrochloride; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fat Emulsions, Intravenous; Female; Humans; Hypertension | 2020 |
Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Problem Behavior; Raynaud Disease | 2019 |
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Canada; Central Nervous System Stimulants; Drug-Related Side Effects and Adverse Reactions; Excitatory Amino Acid Antagonists; France; Germany; Humans; Italy; Memantine; Methylphenidate; Modafinil; Pharmacovigilance; Spain; Substance-Related Disorders; United Kingdom; United States; Wakefulness-Promoting Agents | 2017 |
Second opinions improve ADHD prescribing in a medicaid-insured community population.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cost Savings; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Health Expenditures; Humans; Male; Medicaid; Propylamines; Referral and Consultation; Treatment Outcome; United States; Washington | 2009 |
A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Anticonvulsants; Atomoxetine Hydrochloride; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Infant; Infant, Newborn; Melatonin; Methylphenidate; Pharmacies; Pilot Projects; Propylamines; Prospective Studies; Sample Size; Scotland; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Combining atomoxetine with carbamazepine or neuroleptics reduces adverse side effects.
Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Antipsychotic Agents; Atomoxetine Hydrochloride; Carbamazepine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Propylamines | 2010 |
Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Arrhythmias, Cardiac; Atomoxetine Hydrochloride; Cardiovascular Abnormalities; Death, Sudden; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Myocardial Infarction; Proportional Hazards Models; Propylamines; Stroke | 2013 |